2seventy bio, Inc.
TSVT
$4.95
$2.1576.79%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -9.93M | 24.88M | -52.67M | -56.82M | -71.64M |
Total Depreciation and Amortization | 1.66M | 1.68M | 2.11M | 3.03M | 2.76M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.55M | -47.34M | 6.68M | 3.26M | 19.61M |
Change in Net Operating Assets | -3.78M | -2.36M | 2.01M | -13.07M | 27.75M |
Cash from Operations | -10.51M | -23.14M | -41.88M | -63.60M | -21.51M |
Capital Expenditure | -34.00K | -61.00K | -612.00K | -1.07M | -2.74M |
Sale of Property, Plant, and Equipment | 0.00 | 43.00M | 176.00K | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -41.46M | 35.50M | 22.27M | 48.96M | 18.80M |
Cash from Investing | -41.50M | 78.44M | 21.83M | 47.89M | 16.05M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 52.00K | -- | 386.00K | 253.00K | -- |
Repurchase of Common Stock | -- | -24.00K | -- | -- | -75.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 52.00K | -24.00K | 386.00K | 253.00K | -75.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -51.95M | 55.27M | -19.66M | -15.45M | -5.53M |